Preliminary Program
Stream 1: Basic Oncological Research
|
Forum 1-1: Tumor Microenvironment |
|
|
Day 2: Morning, May 12, 2022 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Speech Opportunity Available |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Speech Opportunity Available |
|
10:55-11:20 |
Speech Opportunity Available |
|
11:20-11:45 |
Speech Opportunity Available |
|
11:45-12:10 |
Speech Opportunity Available |
|
Forum 1-2: Tumor Biology, Cancer System Biology, System Immunology, Molecular Targeted Agents |
|
|
Day 2: Morning, May 12, 2022 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Dr. A. C. Matin, Professor, Stanford University School of Medicine, USA |
|
09:00-09:25 |
Dr. Paul A. Insel, Distinguished Professor of Pharmacology and Medicine, University of California, San Diego, USA |
|
09:25-09:50 |
Dr. Ying Xu, Professor of Biochemistry and Molecular Biology, University of Georgia, USA |
|
09:50-10:15 |
Dr. Bai Xianhong, Chairman, Biotech Pharmaceuticals Co Ltd, China
|
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Dr. Alvaro Macieira-Coelho, Professor, INSERM, France
|
|
10:55-11:20 |
Dr. Abdelhabib Semlali, Professor, Laval University, Canada |
|
11:20-11:45 |
Dr. Severino Rey, Professor, Manises Hospital; Synlab Iberia, Spain
|
|
11:45-12:10 |
Speech Opportunity Available |
|
Forum 1-3: Cancer Drug Resistance and Solutions |
|
|
Day 2: Morning, May 12, 2022 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Title: Deciphering Mechanisms of Resistance to IO Therapies with Computational Approaches Dr. Jadwiga Bienkowska, Senior Director, Head of Computational Biology Oncology R&D, Pfizer, USA
|
|
09:00-09:25 |
Speech Opportunity Available |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Speech Opportunity Available |
|
10:55-11:20 |
Speech Opportunity Available |
|
11:20-11:45 |
Speech Opportunity Available |
|
11:45-12:10 |
Speech Opportunity Available |
|
Forum 1-4: Cancer Metabolism |
|
|
Day 2: Afternoon, May 12, 2022 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:05 |
Speech Opportunity Available |
|
14:05-14:30 |
Speech Opportunity Available |
|
14:30-14:55 |
Speech Opportunity Available |
|
14:55-15:20 |
Speech Opportunity Available |
|
15:20-15:30 |
Coffee Break |
|
15:35-16:00 |
Speech Opportunity Available |
|
16:00-16:25 |
Speech Opportunity Available |
|
16:25-16:50 |
Speech Opportunity Available |
|
16:50-17:15 |
Speech Opportunity Available |
|
Forum 1-5: Cancer Epigenetics, Cancer Genome Instability and Mutation Signatures |
|
|
Day 2: Afternoon, May 12, 2022 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:05 |
Speech Opportunity Available |
|
14:05-14:30 |
Speech Opportunity Available |
|
14:30-14:55 |
Speech Opportunity Available |
|
14:55-15:20 |
Speech Opportunity Available |
|
15:20-15:30 |
Coffee Break |
|
15:35-16:00 |
Speech Opportunity Available |
|
16:00-16:25 |
Speech Opportunity Available |
|
16:25-16:50 |
Speech Opportunity Available |
|
16:50-17:15 |
Speech Opportunity Available |
|
Forum 1-6: Stem Cells and Cancer |
|
|
Day 2: Afternoon, May 12, 2022 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:05 |
Title: TBD Dr. Luzhe Sun, Professor, University of Texas Health Science Center at San Antonio, USA
|
|
14:05-14:30 |
Title: TBD Dr. Barbara Illi, Researcher, National Research Council (CNR), Italy
|
|
14:30-14:55 |
Title: TBD Dr. Haizhong Feng, Professor, Renji-Med X Clinical Stem Cell Research Center, Renji Hospital, Shanghai Jiao Tong University School of Medicine, China
|
|
14:55-15:20 |
Title: The HIF1α/HIF2α-miR210-3p Network Regulates Glioblastoma Cell Proliferation, Dedifferentiation and Chemoresistance through EGF under Hypoxic Conditions
|
|
15:20-15:30 |
Coffee Break |
|
15:35-16:00 |
Title: TBD Dr. Jun Dou, Professor, Southeast University, China
|
|
16:00-16:25 |
Speech Opportunity Available |
|
16:25-16:50 |
Speech Opportunity Available |
|
16:50-17:15 |
Speech Opportunity Available |
|
Forum 1-7: Neuro-Oncology |
|
|
Day 3: Morning, May 13, 2022 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Title: TBD Dr. Jizong Zhao, Academician of Chinese Academy of Sciences, Professor and Chairman, Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China
|
|
09:00-09:25 |
Title: The Neurosurgery for Brain Tumors in the Third Millennium: a Pediatric Experience of More Than 1000 Cases Operated on in a Single Institution Dr. Lorenzo Genitori, Director of the Center of Excellence of Neurosurgery, AOU Meyer, Italy
|
|
09:25-09:50 |
Title: TBD Dr. Chantal Campello, CHU Timone, France
|
|
09:50-10:15 |
Title: TBD Dr. Alisa Taliansky, Neuro-oncologist, Institute of Oncology, Sheba Medical Center at Tel HaShomer, Israel
|
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Speech Opportunity Available |
|
10:55-11:20 |
Title: Immune Microenvironment Landscape in Glioma Dr. Jinquan Cai, The Second Affiliated Hospital of Harbin Medical University, China
|
|
11:20-11:45 |
Speech Opportunity Available |
|
11:45-12:10 |
Speech Opportunity Available |
|
Forum 1-8: Tumor Biomarkers, Molecular Diagnosis and Precision Medicine in Oncology |
|
|
Day 3: Morning, May 13, 2022 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Speech Opportunity Available |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Speech Opportunity Available |
|
10:55-11:20 |
Speech Opportunity Available |
|
11:20-11:45 |
Speech Opportunity Available |
|
11:45-12:10 |
Speech Opportunity Available |
|
Forum 1-9: Pediatric Oncology |
|
|
Day 3: Morning, May 13, 2022 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Dr. Joseph Rosenthal, Professor, City of Hope Comprehensive Cancer Center; Valley Children's Healthcare and Hospital, USA |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Speech Opportunity Available |
|
10:55-11:20 |
Speech Opportunity Available |
|
11:20-11:45 |
Speech Opportunity Available |
|
11:45-12:10 |
Speech Opportunity Available |
|
Forum 1-10: Translational Cancer Research |
|
|
Day 3: Morning, May 13, 2022 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Speech Opportunity Available |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Speech Opportunity Available |
|
10:55-11:20 |
Speech Opportunity Available |
|
11:20-11:45 |
Speech Opportunity Available |
|
11:45-12:10 |
Speech Opportunity Available |
Contact Us: Email:Mandy@bitcongress.com
Company Name: 3F, Building 2, Dalian Life Science Innovation Center, 43 Huoju Road,
Hi-tech Industrial Zone, Dalian City, Liaoning Province, China
Copyright © 2008-2022 BIT Congress